Allogeneic hematopoietic cell transplantation with HLA [human leukocyte antigen]-matched donors: a phase II randomized study comparing 2 nonmyeloablative conditionings.

Trial Profile

Allogeneic hematopoietic cell transplantation with HLA [human leukocyte antigen]-matched donors: a phase II randomized study comparing 2 nonmyeloablative conditionings.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Sep 2016

At a glance

  • Drugs Antithymocyte globulin (Primary) ; Fludarabine
  • Indications Graft-versus-host disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 01 Sep 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2016 as reported by ClinicalTrials.gov.
    • 24 Jun 2010 Planned end date changed from 1 Jul 2012 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top